中国呼吸系统疾病药物利用现状:基于3个数据库比较分析

详细信息    查看全文 | 推荐本文 |

英文篇名：Current Drug Utilization of Respiratory System Disease in China: A Comparative Analysis Based on 3 Databases 作者：赖云锋 ; 陈献文 ; 陈圣琦 ; 郭琰 ; 别瑞雪 ; 韩晟 ; 史录文 ; 胡豪 英文作者：LAI Yun-Feng;CHEN Xian-Wen;CHEN Sheng-Qi;GUO Yan;BIE Rui-Xue;HAN Sheng;SHI Lu-Wen;HU Hao;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau;School of Pharmacy,International Research Center for Pharmaceutical Management,Peking University; 关键词：药物利用 ; 呼吸系统疾病 ; CHIS数据库 ; PDB数据库 ; MENET数据库 英文关键词：Drug utilization;;Respiratory system disease;;CHIS database;;PDB database;;MENET database 中文刊名：ZYWA 英文刊名：China Journal of Pharmaceutical Economics 机构：中药质量研究国家重点实验室/中华医药研究院/澳门大学;北京大学药学院北京大学医药管理国际研究中心; 出版日期：2019-01-15 15:58 出版单位：中国药物经济学 年：2019 期：v.14;No.109 基金：国家自然科学基金青年项目(71603008,基于非随机指数理论模型的中国医院药品费用增长构成研究);; 澳门大学研究委员会课题(MYRG2018-00012-ICMS) 语种：中文; 页：ZYWA201901005 页数：5 CN：01 ISSN：11-5482/R 分类号：23-27

摘要

目的通过实证分析不同渠道医院呼吸系统用药相关数据,了解中国呼吸系统疾病药物利用现状。方法从中国三个医药市场数据库(CHIS数据库、PDB数据库和MENET数据库)获取医院呼吸系统疾病用药相关数据,利用Excel软件进行整理、分析,了解中国呼吸系统疾病药物利用现状。结果基于多渠道的CHIS数据分析发现,以咳嗽和感冒用药为主的呼吸系统疾病用药整体增长放缓;基于重要城市医院渠道的PDB数据分析发现,以平喘药为主的呼吸系统疾病用药增长较快;基于重点城市公立医院渠道的MENET数据分析发现,城市公立医院的呼吸系统疾病用药增长最快。结论中国呼吸系统疾病用药整体呈增长趋势,但不同渠道增长有所不同。
        Objectives To explore the current drug utilization of respiratory system disease in China through empirical analysis of data on hospital respiratory system medications in different channels. Methods The drug utilization data of respiratory system disease in hospitals were obtained from three different Chinese pharmaceutical market databases(CHIS database, PDB database and MENET database). Excel software was used to collate and analyze the data, and to understand the drug utilization of respiratory system disease in China. Results CHIS data analysis based on multi-channel data found that the overall growth of the use of drugs for respiratory system diseases, mainly cough and cold preparations, had slowed down. PDB data analysis based on major urban hospital channels found that the use of drugs for respiratory system diseases, mainly antiasthmatic drugs, had increased rapidly; MENET data analysis based on public hospital channels in key cities found that drugs for respiratory system diseases in public hospital had become the biggest growth area. Conclusion Drug use for respiratory diseases in China is on the rise as a whole, but the growth is different in different channels.

引文

[1]WHO.Global status report on noncommunicable diseases 2010:description of the global burden of NCDs,their risk factors and determinants[R].2011.
    [2]俞美玲,赵湘,黄李春,等.专家解读《中国居民营养与慢性病状况报告(2015)》[J].健康博览,2015,24(8):4-10.
    [3]许杨,张鹏俊,杨汀,等.我国基层慢性阻塞性肺疾病防治现状研究[J].中国全科医学,2016,19(34):4153-4158.
    [4]中华人民共和国国家卫生和计划生育委员会.2017中国卫生和计划生育统计年鉴[M].北京:中国协和医科大学出版社,2017.
    [5]Yang G,Wang Y,Zeng Y,et al.Rapid health transition in China,1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2013,381(9882):1987-2015.
    [6]彭博,张鹏俊,吴司南,等.我国基层医疗卫生机构慢性呼吸系统疾病管理现状研究[J].中国全科医学,2018,21(13):1513-1520.
    [7]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志,2016,39(9):675-697.
    [8]Lin J,Wang W,Chen P,et al.Prevalence and risk factors of asthma in mainland China:The CARE study[J].Respiratory medicine,2018,137:48-54.
    [9]李继忠,边毓尧,郭文有,等.PM2.5与呼吸系统疾病发病率关系流行病学调查研究[J].陕西医学杂志,2018,47(6):805-808.
    [10]Guan WJ,Zheng XY,Chung KF,et al.Impact of air pollution on the burden of chronic respiratory diseases in China:time for urgent action[J].The lancet,2016,388:1939-1951.
    [11]李凡,盛春风,高臻,等.浅述呼吸门诊综合诊疗中心在慢性呼吸系统疾病分级诊疗中的作用[J].中国全科医学杂志,2018:1-6.